Abstract:Damage from occupational or accidental exposure to ionising radiation is often assessed by monitoring chromosome aberrations in peripheral blood lymphocytes, and these procedures have, in several cases, assisted physicians in the management of irradiated persons. Thereby, circulating lymphocytes, which are in the G0 stage of the cell cycle are stimulated with a mitogenic agent, usually phytohaemagglutinin, to replicate in vitro their DNA and enter cell division, and are then observed for abnormalities. Comparison with dose-response relationships obtained in vitro allows an estimate of exposure based on scoring: Unstable aberrations by the conventional, well-established analysis of metaphases for chromosome abnormalities or for micronuclei; So-called stable aberrations by the classical G-banding (Giemsa-Stain-banding) technique or by the more recently developed fluorescent in situ hybridisation (FISH) method using fluorescent-labelled probes for centromeres and chromosomes. Three factors need to be considered in applying such biological dosimetry: (1) Radiation doses in the body are often inhomogeneous. A comparison of the distribution of the observed aberrations among cells with that expected from a normal poisson distribution can allow conclusions to be made with regard to the inhomogeneity of exposure by means of the so-called contaminated poisson distribution method; however, its application requires a sufficiently large number of aberrations, i.e. an exposure to a rather large dose at a high dose rate. (2) Exposure can occur at a low dose rate (e.g. from spread or lost radioactive sources) rendering a comparison with in vitro exposure hazardous. Dose-effect relationships of most aberrations that were scored, such as translocations, follow a square law. Repair intervening during exposure reduces the quadratic component with decreasing dose rate as exposure is spread over a longer period of time. No valid solution for this problem has yet been developed, although, in theory, both deterministic damage and aberrations might be repaired to a similar degree; a comparison of aberrations following a linear dose relationship might also help when the doses have been sufficiently large. (3) Investigations might have been possible only a certain time after the exposure. The relatively rapid disappearance of lymphocytes carrying unstable aberrations limits their use in retrospective dosimetry, years after exposure. Scoring stable aberrations, thought to persist in the circulating lymphocytes, might appear more appropriate in such situations. However, the examination of a representative number of cells by G-banding is extremely laborious, and the FISH method is not only expensive but has not yet been fully validated in different laboratories. In conclusion, biological dosimetry has serious limitations exactly for situations where the need for information is most urgent. It renders its most useful results when an individual has been exposed to a rather homogeneous high-level radiation over a short time interval, i.e. accidents at high-intensity radiation devices. On the other hand, it yielded less satisfactory information even when the most recent techniques were used for situations, where a low level, low dose rate exposure has occurred at some time in the past, for example for persons living in areas contaminated from the Chernobyl accident. Such negative experiences should be kept in mind in order to avoid futile and expensive investigations in the case of populations exposed from radioactivity and, notably, also from potentially clastogenic chemical agents.

Persons chronically exposed to low doses of ionizing radiation: A cytogenetic dosimetry study

Retrospective biodosimetry techniques: Focus on cytogenetics assays for individuals exposed to ionizing radiation

Cytogenetic follow-up studies on humans with internal and external exposure to ionizing radiation

Validation of a High-Throughput Dicentric Chromosome Assay Using Complex Radiation Exposures

Dose-Dependent Shift in Relative Contribution of Homologous Recombination to DNA Repair after Low-LET Ionizing Radiation Exposure: Empirical Evidence and Numerical Simulation

Usefulness and limits of biological dosimetry based on cytogenetic methods

Radiation adaptive response for constant dose-rate irradiation in high background radiation areas

Application of dosimetry systems and cytogenetic status of the child population exposed to diagnostic X-rays by use of the cytokinesis-block micronucleus cytome assay

Lifetime study in mice after acute low-dose ionizing radiation: a multifactorial study with special focus on cataract risk

Human individual radiation sensitivity and prospects for prediction

An investigation of the age-dependency of chromosome abnormalities in human populations exposed to low-dose ionising radiation

Model of age-dependent dynamics and biokinetics of T-cells as natural biodosimeters

Differential biological effect of low doses of ionizing radiation depending on the radiosensitivity in a cell line model

Investigating the impact of long term exposure to chemical agents on the chromosomal radiosensitivity using human lymphoblastoid GM1899A cells

Medical personnel occupationally exposed to low-dose ionising radiation in Federation of Bosnia and Herzegovina: A cytogenetic study

Results of studying pro- and anti-atherogenic immune factors in the persons chronically exposed to ionising radiation

Dependence of the human leukemia risk on the dose and dose rate of continuous irradiation: Modeling study

Perturbed transcriptional profiles after chronic low dose rate radiation in mice

Candidate biomarkers and persistent transcriptional responses after low and high dose ionizing radiation at high dose rate

The Double Threshold: Consequences for Identifying Low-Dose Radiation Effects

Biodosimetry Estimate for High-Let Irradiation